CD274 and neoplasm: As for other tumor-types, generous cut-offs and scoring criteria (≥1%, CPS) may sometimes easily allow the pathologist to consider a case as positive; thus, it can be debated if the efficacy of the administered drug is related to a very focal PD-L1 immunohistochemical expression.